Dr amala kompella

Established and led preclinical discovery department, advanced PI3K and immuno-oncology programs, and managed process development and scale-up of multiple oncology APIs including imatinib mesylate with production at 400 kg plant scale.

Led R&D efforts across discovery and process development, contributed to imatinib mesylate process innovation (alpha-2 crystal form) and secured patents and industry awards for cost-effective industrial processes.

Executed process development for active pharmaceutical ingredients, focusing on scalable, industrially viable synthetic routes and impurity control.

Developed and stabilized benzenoid aromatic processes, optimizing yields and product stability for manufacturing applications.

Conducted process development of benzenoid aromatics, improving synthetic routes and transferability to pilot-scale production.

Taught undergraduate chemistry courses and supervised practical laboratory sessions for chemistry students.

Ph.D. with thesis titled 'Therapeutically useful phenylamino pyrimidines' completed between 2007 and 2014.

Grade: I division

Diploma in Advanced Computer Technology, awarded First Division in 2000.

Grade: 73%

Completed M.Sc. in Chemistry with 73% and University 3rd rank in 1992.